Publications

by | September 26, 2014 | Uncategorized

5th ESWI Influenza Conference highlights benefits of vaccination

The fifth international influenza conference organised by EPHA member the European Scientific Working Group on Influenza (ESWI) took place in Riga on 14-17 September. A number of plenary and ‘science/policy interface’ sessions examined the issue of low vaccination uptake in many Member States, as well as other issues related to pandemic preparedness and communication aspects of influenza-related health threats.

In the opening plenary, ’Why should influenza be a public health priority?’, ESWI Chair Professor Ab Osterhaus (Erasmus MC, Netherlands) recalled the ESWI’s function in engaging stakeholders in discussing relevant issues related to prevention, treatment and diagnosis. European Commissioner for Health and Consumer Policy, Tonio Borg, reiterated the EU’s recent work on the health threats field, including the Decision on Serious Cross-border Threats and the Joint Procurement Agreement that was signed in June 2014. He stressed the importance of adopting a strategic and life-course approach to immunisation and of integrating it into national health systems. In January, the Commission had issued a progress report on seasonal flu and Borg noted that vaccination coverage needs to be increased. The Italian EU Presidency was also prioritising this issue as part of its Council Conclusions. According to Borg, it was important to consider vaccination as a key public health tool.

ECDC Director Marc Sprenger recalled his tripartite dream of good surveillance, high vaccination coverage and effective vaccines. He delivered a ‘wake-up call’ calling for urgent changes: while Europe had an excellent surveillance mechanism, it was important to produce better vaccines in order to increase public confidence and vaccine uptake. In Europe, only two countries – the Netherlands and the UK – attained the 75% vaccination target for priority risk groups whereas in some Member States this percentage was under 10%. Similarly, many health workers refused to get vaccinated around Europe. Only effective products could achieve higher acceptance, and it was important to have good evidence, especially regarding older people.

During the ‘spi track’ sessions, Professor Osterhaus recalled that influenza is a moving target: a global health threat that followed human mobility patterns. Hence pandemic risk emanating from zoonotic transmission by avian and swine populations needs to be taken seriously. He explained that only a handful of mutations were necessary for dangerous flu strains to become transmissible. Regarding seasonal influenza, vaccine composition needed to be reviewed annually due to antigenic drift. Participants including the WHO and ECDC repeatedly emphasised the importance of closing vaccination coverage and erosion gaps, especially since 1 out of every 5 children still did not receive basic vaccines. Lack of knowledge and access / affordability issues were part of the problem, and it is vital to address these challenges in an inclusive, non-controversial way.

Among the many other issues discussed, the following issues are of particular interest to the public health community:

  • The need for better data on the effects of flu vaccination amongst pregnant women, young children and the elderly, and its potential to protect against diseases such as pneumonia and coronary heart disease
  • Better cross-sectoral cooperation, e.g. between flu researchers and health professionals (cardiologists, etc.)
  • Improved communication of influenza health threats (including clear messages, direction, strategy) to politicians concerned about public opinion and the consequences of receiving ambiguous information and negative media reports
  • Economic aspects of influenza disease burden, cross-border and global health security: everybody’s health is at risk
  • The prospects of future global flu vaccines providing broad protection against highly variable, unpredictable flu viruses
  • Proactive risk communication using social media and addressing concerns voiced by the public and by ‘vaccination sceptics’ (including parents)
  • Applying the lessons learned from seasonal flu preparedness for pandemic preparedness (example provided by NHS London)
  • Revised WHO phases and introduction of pandemic risk management plans that are also applicable to other health hazards, providing flexibility at country level
  • Viewing influenza and other health threats as civil emergencies rather than merely health-related problems

Some of these issues will be taken up further in the upcoming EPHA Briefing on Vaccination, elaborated in collaboration with the ESWI.

Get the EPHA Newsletter

The best of our activities, right in your inbox!